H2 inhalation therapy in patients with moderate COVID-19 (H2COVID): a prospective ascending-dose phase I clinical trial
Article in Antimicrobial Agents and Chemotherapy (July 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
The Effect of 14-Day Consumption of Hydrogen-Rich Water Alleviates Fatigue but Does Not Ameliorate Dyspnea in Long-COVID Patients: A Pilot, Single-Blind, and Randomized, Controlled Trial
Article in Nutrients (May 2024)
H2 inhalation therapy in patients with moderate Covid 19 (H2 COVID): a prospective ascending-dose phase 1 clinical trial
Preprint in medRxiv (March 2024)